Jones Adam P, Haley Michael J, Meadows Miriam H, Gregory Grace E, Hannan Cathal J, Simmons Ana K, Bere Leoma D, Lewis Daniel G, Oliveira Pedro, Smith Miriam J, King Andrew T, Evans D Gareth R, Paszek Pawel, Brough David, Pathmanaban Omar N, Couper Kevin N
Division of Immunology, Immunity to Infection and Respiratory Medicine, Faculty of Biology, Medicine & Health, The University of Manchester, Manchester, UK.
Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance NHS Foundation Trust, University of Manchester, Manchester, UK.
Nat Commun. 2025 Mar 26;16(1):2944. doi: 10.1038/s41467-025-57586-z.
NF2-related Schwannomatosis (NF2 SWN) is a rare disease characterised by the growth of multiple nervous system neoplasms, including bilateral vestibular schwannoma (VS). VS tumours are characterised by extensive leucocyte infiltration. However, the immunological landscape in VS and the spatial determinants within the tumour microenvironment that shape the trajectory of disease are presently unknown. In this study, to elucidate the complex immunological networks across VS, we performed imaging mass cytometry (IMC) on clinically annotated VS samples from NF2 SWN patients. We reveal the heterogeneity in neoplastic cell, myeloid cell and T cell populations that co-exist within VS, and that distinct myeloid cell and Schwann cell populations reside within varied spatial contextures across characteristic Antoni A and B histomorphic niches. Interestingly, T-cell populations co-localise with tumour-associated macrophages (TAMs) in Antoni A regions, seemingly limiting their ability to interact with tumorigenic Schwann cells. This spatial landscape is altered in Antoni B regions, where T-cell populations appear to interact with PD-L1 Schwann cells. We also demonstrate that prior bevacizumab treatment (VEGF-A antagonist) preferentially reduces alternatively activated-like TAMs, whilst enhancing CD44 expression, in bevacizumab-treated tumours. Together, we describe niche-dependent modes of T-cell regulation in NF2 SWN VS, indicating the potential for microenvironment-altering therapies for VS.
与神经纤维瘤病2型相关的神经鞘瘤病(NF2 SWN)是一种罕见疾病,其特征是多个神经系统肿瘤生长,包括双侧前庭神经鞘瘤(VS)。VS肿瘤的特征是大量白细胞浸润。然而,VS中的免疫格局以及塑造疾病发展轨迹的肿瘤微环境中的空间决定因素目前尚不清楚。在本研究中,为了阐明VS中的复杂免疫网络,我们对来自NF2 SWN患者的临床注释VS样本进行了成像质谱流式细胞术(IMC)。我们揭示了VS中共存的肿瘤细胞、髓样细胞和T细胞群体的异质性,以及不同的髓样细胞和雪旺细胞群体存在于特征性Antoni A和B组织形态龛的不同空间结构中。有趣的是,T细胞群体在Antoni A区域与肿瘤相关巨噬细胞(TAM)共定位,似乎限制了它们与致瘤雪旺细胞相互作用的能力。这种空间格局在Antoni B区域发生改变,在该区域T细胞群体似乎与PD-L1雪旺细胞相互作用。我们还证明,在接受贝伐单抗治疗的肿瘤中,先前的贝伐单抗治疗(VEGF-A拮抗剂)优先减少交替激活样TAM,同时增强CD44表达。我们共同描述了NF2 SWN VS中T细胞调节的龛依赖性模式,表明VS有微环境改变疗法的潜力。